We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Glaxo Investors Vie For Lead Plaintiff Role

Law360 (September 10, 2007, 12:00 AM EDT) -- Three parties vying to serve as lead plaintiff in a securities action against pharmaceutical giant GlaxoSmithKline PLC exchanged volleys Friday, each arguing it is best-suited to represent the proposed class of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.